Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
The Journal of Pathology|August 8, 2015
Myeloid cell-mediated renal injury in rapidly progressive glomerulonephritis depends upon spleen tyrosine kinaseJessica Ryan, Frank Y Ma, Yingjie Han, et al.Frontiers in Physiology|January 23, 2023
Corrigendum: c-Jun amino terminal kinase signaling promotes aristolochic acid-induced acute kidney injuryFan Yang, Elyce Ozols, Frank Y Ma, et al.Frontiers in Physiology|March 1, 2021
c-Jun Amino Terminal Kinase Signaling Promotes Aristolochic Acid-Induced Acute Kidney InjuryFan Yang, Elyce Ozols, Frank Y Ma, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|February 4, 2009
Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the ratFrank Y Ma, Robert S Flanc, Greg H Tesch, et al.International Journal of Immunopathology and Pharmacology|October 3, 2024
A gradient model of renal ischemia reperfusion injury to investigate renal interstitial fibrosisFan Yang, Baoping Zhu, Elyce Ozols, et al.International Journal of Molecular Sciences|January 1, 2021
Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial FibrosisKhai Gene Leong, Elyce Ozols, John Kanellis, et al.Journal of the American Society of Nephrology : JASN|April 5, 2014
Myeloid mineralocorticoid receptor activation contributes to progressive kidney diseaseLouis L Huang, David J Nikolic-Paterson, Yingjie Han, et al.The American Journal of Pathology|February 19, 2021
JUN Amino-Terminal Kinase 1 Signaling in the Proximal Tubule Causes Cell Death and Acute Renal Failure in Rat and Mouse Models of Renal Ischemia/Reperfusion InjuryKeren Grynberg, Elyce Ozols, William R Mulley, et al.Journal of Cellular and Molecular Medicine|July 13, 2018
ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritisLiv A Amos, Frank Y Ma, Greg H Tesch, et al.Frontiers in Pharmacology|February 16, 2026
A new Jun amino-terminal kinase inhibitor, KRev-202, inhibits rat ischemic acute injury and the progression to renal fibrosisDavid J Nikolic-Paterson, Greg H Tesch, Elyce Ozols, et al.Pageof 5